Benitec Biopharma (NASDAQ:BNTC) Receives Market Outperform Rating from JMP Securities
Benitec Biopharma (NASDAQ:BNTC – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a research report issued on Thursday,Benzinga reports. They currently have a $20.00 price target on the biotechnology company’s stock. JMP Securities’ price objective suggests a potential upside of 47.06% from the stock’s current price. […]
Benitec Biopharma (NASDAQ:BNTC – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a research report issued on Thursday,Benzinga reports. They currently have a $20.00 price target on the biotechnology company’s stock. JMP Securities’ price objective suggests a potential upside of 47.06% from the stock’s current price. […]
